Showing results (491-500 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|June 20, 2014
Drug therapy for advanced-stage liver cancerMarkus Peck-Radosavljevic
Liver Cancer|June 12, 2018
Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II StudyMasatoshi Kudo, Yoon-Koo Kang, Joong-Won Park, et al.
Liver Cancer|August 11, 2022
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver CancersJames J Harding, Ahmad Awada, Gael Roth, et al.
Liver Cancer|August 11, 2022
A Hybrid Machine Learning Model Based on Semantic Information Can Optimize Treatment Decision for Naïve Single 3-5-cm HCC PatientsWenzhen Ding, Zhen Wang, Fang-Yi Liu, et al.
Liver Cancer|August 20, 2025
Prognostic Value of Clinical Complete Response for Patients with Initially Unresectable Hepatocellular Carcinoma after Conversion with Triple TherapyJun-Yi Wu, Zhen-Xin Zeng, Yi-Nan Li, et al.
Liver Cancer|March 6, 2023
Surgical Outcomes of Laparoscopic versus Open Hepatectomy for Left Hepatocellular Carcinoma: Propensity Score Analyses Using Retrospective Japanese and Korean Individual Patient DataMasaki Kaibori, Kengo Yoshii, Yuzo Umeda, et al.
Liver Cancer|March 6, 2023
Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver DiseaseHaonan Lu, Jacob George, Mohammed Eslam, et al.
Liver Cancer|October 22, 2024
Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECTRichard S Finn, Shukui Qin, Fabio Piscaglia, et al.
Liver Cancer|October 22, 2024
Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of TaiwanWei Teng, Hung-Wei Wang, Shi-Ming Lin, et al.
Liver Cancer|August 8, 2024
A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394Shukui Qin, Weijia Fang, Zhenggang Ren, et al.
Pageof 55